CABA Cabaletta Bio, Inc.
Healthcare$3.72+1.92%ClosedMarket Cap: $358.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.96
P/S
0.00
EV/EBITDA
-1.52
DCF Value
$0.49
FCF Yield
-40.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-131.6%
ROA
-118.4%
ROIC
-138.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-44.3M | $-43.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-42.6M | $-41.9M | $— | — |
| FY null | $0.00 | NaN% | $-172.2M | $-167.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-46.6M | $-44.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-45.9M | $-45.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-37.1M | $-35.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-33.8M | $-32.6M | $— | — |
| FY null | $0.00 | NaN% | $-125.1M | $-115.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-33.0M | $-30.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-30.3M | $-27.6M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-28.0M | $-25.0M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-23.1M | $-20.9M | $-0.47 | — |